CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
Shu Su, Bian Hu, Jie Shao et al. · Scientific Reports · 2016
Full textCC BY
Shu Su, Bian Hu, Jie Shao et al. · Scientific Reports · 2016
Full textCC BY
Matthew J. Blow, Tyson A. Clark, Chris G. Daum et al. · PLOS Genetics · 2016
Full textCC0
Bin Huang, Wenhao Wang, Qingchu Li et al. · Nature Communications · 2016
Full textCC BY
Ann Hanna, Lalita A. Shevde · Molecular Cancer · 2016 · Review
Full textCC BY
Richard L. Hahnke, Jan P. Meier-Kolthoff, Marina García-López et al. · Frontiers in Microbiology · 2016
Full textCC BY
Paul Muir, Shantao Li, Shaoke Lou et al. · Genome Biology · 2016
Full textCC BY
Eunsoo Lee, Jungyoon Choi, Youhwa Jo et al. · Scientific Reports · 2016
Full textCC BY
Mathias S. Dick, Lorenzo Sborgi, Sebastian Rühl et al. · Nature Communications · 2016
Full textCC BY
Jinwoo Leem, James Dunbar, Guy Georges et al. · mAbs · 2016
Full textCC BY
Wael Nassar, Mervat El-Ansary, Dina Sabry et al. · Biomaterials Research · 2016
Full textCC BY
Lingling Jiang, Yingying Shen, Danfeng Guo et al. · Nature Communications · 2016
Full textCC BY
Akbar K. Waljee, Wyndy L. Wiitala, Shail Govani et al. · PLOS ONE · 2016
Full textCC0
Saudi Mendeliome Group · Genome Biology · 2015
Full textCC BY
Giulio Cossu, Stefano C Previtali, Sara Napolitano et al. · EMBO Molecular Medicine · 2015
Full textCC BY
Patricio Godoy, Wolfgang Schmidt-Heck, Karthick Natarajan et al. · Journal of Hepatology · 2015
Full textCC BY
Sun Jianqin, Xu Leiming, Xia Lu et al. · Nutrition Journal · 2015 · Randomised trial
Full textCC BY
Mehmet A. Orman, Mark P. Brynildsen · Nature Communications · 2015
Full textCC BY
Chloe Girard, Liudmila Chelysheva, Sandrine Choinard et al. · PLOS Genetics · 2015
Full textCC BY
Christina D. Orrú, Bradley R. Groveman, Lynne D. Raymond et al. · PLOS Pathogens · 2015
Full textCC0
Van T. M. Nguyen, Iros Barozzi, Monica Faronato et al. · Nature Communications · 2015
Full textCC BY